Liquid fluoride can prevent cavities without the need for drilling, major study reveals

Liquid fluoride can prevent cavities without the need for drilling, major study reveals

It seems that dentists may soon have a simpler way to tackle cavities.

Researchers from the University of Michigan have completed a significant Phase III trial that tested a liquid fluoride treatment on cavities in children. The results showed that this treatment was much more effective than a placebo in preventing additional tooth decay, potentially sparing kids from more invasive procedures like fillings or surgery.

The researchers concluded that liquid fluoride could be a viable “noninvasive treatment for high-risk young children” and suggested it be considered for FDA approval, according to their paper, published in July in JAMA Pediatrics.

Currently off-label

Cavities, or caries, are the result of bacteria creating holes in the protective enamel of teeth. While it seems that dental care has improved over the years, over 40% of children in the U.S. still develop some degree of tooth decay. Conventional treatments usually involve fillings, though severe cases may lead to the need for more intrusive procedures like root canals or even tooth extractions.

Fluoride is widely recognized for its cavity-prevention properties, which is why many governments add it to drinking water. It also appears to help stop the further deterioration of existing cavities. Some countries have approved various fluoride treatments, such as silver diamine fluoride (SDF), for this purpose. However, the U.S. has not yet included SDF in its approved list.

In 2014, the FDA greenlighted SDF for treating tooth sensitivity, allowing its off-label use for cavities. By 2016, the FDA classified SDF as a “breakthrough” therapy, aimed at speeding up the review process for promising treatments. However, the lack of strong evidence regarding its safety and effectiveness makes it unlikely that the FDA will approve SDF for this purpose anytime soon.

This trial, partly funded by the U.S. National Institutes of Health, aims to fill that evidence gap.

Solid evidence

The study included 830 children under six years old with severe early childhood cavities. Half of the participants were given a placebo, while the other half received a 38% formulation of SDF, applied directly to the affected areas with a small sponge. They received their first treatment at the study’s outset and a second dose six months later, then were monitored for cavities over the next eight months.

By the end of the trial, 70% of the children finished the study. After eight months, about 50% of the SDF group showed no worsening of their cavities, while only 17% in the placebo group had similar results.

It’s worth noting that SDF can cause a permanent darkening of teeth due to the silver content, but the side effects reported were fairly similar across both groups. For kids who will eventually lose their baby teeth, this cosmetic concern is likely less significant.

The researchers believe their findings could bolster the case for FDA approval of SDF. Margherita Fontana, a professor of dentistry at the University of Michigan School of Dentistry, remarked, “To benefit more children and families, we need robust evidence showing it works and is safe. If we aim for broader use in the U.S., especially in medical environments, we need well-documented data from U.S. populations, and we have that now.”

While SDF is primarily aimed at younger children, it may also serve as a useful temporary solution for adults who can’t access or afford other treatments.

“For essentially anyone, this could halt decay and alleviate the pain associated with infection,” Fontana noted. “This could truly help a lot of people.”

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News